Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the launch of its next-generation digital pathology solution, moving digital ...
LabCorp® (NYSE: LH), a leading global life sciences company that is deeply integrated in guiding patient care, and Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today ...
Amsterdam, The Netherlands and Tel Aviv, Israel – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Ibex Medical Analytics, a pioneer in artificial intelligence (AI) ...
Amsterdam, the Netherlands and Orlando, USA – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced an expanded collaboration with Amazon Web Services (AWS) to ...
AI-based cancer assessment tools are poised to help pathologists improve speed and accuracy of cancer diagnostics, ultimately leading to better patient care Pathologists play a crucial role in the ...
AMSTERDAM--(BUSINESS WIRE)--Royal Philips (NYSE: PHG, AEX: PHIA) today announced that it has acquired PathXL, a Northern Ireland-based leader in digital pathology image analysis, workflow software and ...
Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced it has received regulatory clearance (via De Novo classification) from the U.S.
FDA cleared Philips IntelliSite Pathology Solution (PIPS) under its De Novo pathway in 2017. The product is the first whole-slide imaging system with digital surgical pathology slide review features ...
Royal Philips and LabPON, the first clinical laboratory to transition to 100% histopathology digital diagnosis, today announced its plans to create a digital database of massive aggregated sets of ...
Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the launch of its next-generation digital pathology solution, moving digital ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results